Press "Enter" to skip to content

Hormone Replacement Therapy Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024

Hormone

The “Hormone Replacement Therapy Market” 2019 report provides market size (value and volume), market share, growth rate by types, applications, and combines both qualitative and quantitative methods to make micro and macro forecasts in different regions or countries. Hormone Replacement Therapy Market report also aims to provide useful and comprehensive insights into current market trends and future growth scenarios. Hormone Replacement Therapy market report contains information like SWOT analysis, business highlights, strength, weakness, threats and opportunities of industry.

Top Manufacturers of Hormone Replacement Therapy Market Are:

  • Abbott Laboratories
  • Bayer AG
  • Eli Lilly and Company
  • F. Hoffmann
  • La Roche
  • Hisamitsu Pharmaceutical Co. Inc.
  • Merck KGaA
  • Mylan NV
  • Novartis AG
  • Novo Nordisk AS
  • Pfizer Inc.

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14244100

    Market Overview:

  • The market for hormone replacement therapy is expected to witness a CAGR of approximately 6.5%, over the forecast period. Certain factors that are positively affecting the market growth are increasing awareness on post-menopausal issues among women, rise in drug development with novel delivery systems, and hormonal imbalance disorders with rising geriatric population.
  • Hormonal imbalance disorders, with an increase in the geriatric population, is one of the major factors responsible for the growth of the market studied. With various kinds of hormonal changes, the female body predominantly gets affected by the natural process of aging, leading to abnormalities and diseases. Some of the common problems include weight gain, memory decline, fatigue, low libido, aging appearance, and muscle loss.
  • The most frequently reported consequence of age-related hormonal changes occurs in cases related to menopause. The global average onset age for menopause among women is approximately 50 years. In women, by the age of 50 years and above, the production levels of estrogen and progesterone decrease significantly. The decrease in production levels of estrogen and progesterone are compensated by the pituitary gland, with the increased production of follicle stimulating hormone (FSH). This is physically manifested in women in the form of post-menopause symptoms, which include flush. In the United States, up to 10% of women are diagnosed with polycystic ovary syndrome (PCOS), nearly 6% of married women below the age of 45 years suffer from infertility, and nearly 8% men under the age of 45 years receive fertility treatment during their lifetime.
  • These factors associated with age lead to the rising demand for HRT, thus driving the market studied.

    Scope of the Report:

  • Hormone replacement therapy (HRT) is a treatment technique for replacing and/or replenishing hormones in the human body, which are at inadequate levels than those required for the normal physiology of the human body. The most prominent application of HRT is in the treatment of symptom alleviation of menopause.

    Hormone Replacement Therapy Market Report Answers the Following Questions:

    • What will the market size and the growth rate be in 2024?
    • What are the key factors driving the global Hormone Replacement Therapy market?
    • What are the key market trends impacting the growth of the global Hormone Replacement Therapy market?
    • What are the challenges to market growth?
    • Who are the key vendors in the global Hormone Replacement Therapy market?
    • What are the market opportunities and threats faced by the vendors in the global Hormone Replacement Therapy market?
    • Trending factors influencing the market shares of the relevant regions.
    • What are the key outcomes of the five forces analysis of the global Hormone Replacement Therapy market?

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14244100

    Key Market Trends:

    In Therapy Segment, Estrogen Replacement Therapy is Expected to Show the Fastest Growth, over the Forecast Period

    The most common form of estrogen replacement therapy (ERT) is oral medication. Besides, ERT is also available in the commercial market, in the form of pills, patches, and suppositories.

    The most prominently consumed oral ERT variants include conjugated estrogens (Premarin), estradiol (Estrace), and Estratab. ERTs are an effective treatment option for female patients suffering from menopause symptoms. However, there are several side effects associated with the usage of ERTs. Oral ERTs are associated with strokes, blood clots, and some cases of cancer. These side effects have been well documented in the form of moderate-severe adverse drug reactions (ADRs).

    These ADRs are expected to cause some erosion in the popularity of ERTs. However, their adoption rate is expected to increase over the forecast period, globally, due to the increasing prevalence of hormonal imbalance issues among the geriatric people and pregnant women.

    United States Holds the Largest Share in the North American Region

    Rising geriatric population is one of the primary factors responsible for the growth of the hormonal replacement therapy market in the United States.

    According to the National Institutes of Health (NIH), almost half of all the postmenopausal women in the United States reported having used HRT at least once in their life. The conjugated equine estrogens (CEE)/bazedoxifene tablet, a combination of estrogen and a selective estrogen receptor modulator, is available in the United States for menopausal VMS treatment and osteoporosis prevention.

    Three organizations, namely, the American College of Obstetricians and Gynecologists, the North American Menopause Society (NAMS), and the Endocrine Society, have produced guidelines on the use of HRT during menopause. As of 2016, there were 15 producers of estrogens and eight producers of progestins. In 2016, the top-selling HRT-based drug was Premarin, with a market share greater than 50% among HRTs. Consequently, Premarin became the fifth most prescribed drug in the country.

    Overall, the market for HRT in the United States is scheduled for high growth over the forecast period. The major drivers of this market are expected to increase the adoption of HRT among women, for both post-menopausal and menopause management.

    Market Dynamics: –

    • Drivers: (Developing regions and growing markets)
    • Limitations: (Regional, Key Player facing Issues, Future Barriers for growth)
    • Opportunities: (Regional, Growth Rate, Competitive, Consumption)

    The report provides key statistics on the market status of the Hormone Replacement Therapy Market manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the Hormone Replacement Therapy .

    Purchase this Report (Price 4250 USD for single user license) – https://www.industryresearch.co/purchase/14244100

    Report Objectives:

    • Analyzing the size of the Hormone Replacement Therapy market on the basis of value and volume.
    • Accurately calculating the market segments, consumption, and other dynamic factors of different sections of the global Hormone Replacement Therapy market.
    • Determining the key dynamics of the Hormone Replacement Therapy market.
    • Highlighting significant trends of the Hormone Replacement Therapy market in terms of manufacture, revenue, and sales.
    • Deeply summarizing top players of the Hormone Replacement Therapy market and showing how they compete in the industry.
    • Studying industry processes and costs, product pricing, and various trends related to them.
    • Displaying the performance of different regions and countries in the global Hormone Replacement Therapy market.

    Detailed TOC of Hormone Replacement Therapy Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Awareness on Post-menopausal Issues among Women
    4.2.2 Rise in Drug Development with Novel Delivery Systems
    4.2.3 Hormonal Imbalance Disorders with Rising Geriatric Population
    4.3 Market Restraints
    4.3.1 High Cost of Hormone Replacement Therapy
    4.3.2 Substantial Risk of Cancer Associated with Hormone Replacement Therapy
    4.4 Porter’s Five Forces Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Therapy
    5.1.1 Estrogen Hormone Replacement
    5.1.2 Growth Hormone Replacement
    5.1.3 Thyroid Hormone Replacement
    5.1.4 Testosterone Replacement
    5.2 By Route of Administration
    5.2.1 Oral
    5.2.2 Parenteral
    5.2.3 Other Routes of Administration
    5.3 By Disease
    5.3.1 Menopause
    5.3.2 Hypothyroidism
    5.3.3 Growth Hormone Deficiency
    5.3.4 Other Diseases
    5.4 Geography
    5.4.1 North America
    5.4.1.1 United States
    5.4.1.2 Canada
    5.4.1.3 Mexico
    5.4.2 Europe
    5.4.2.1 Germany
    5.4.2.2 United Kingdom
    5.4.2.3 France
    5.4.2.4 Italy
    5.4.2.5 Spain
    5.4.2.6 Rest of Europe
    5.4.3 Asia-Pacific
    5.4.3.1 China
    5.4.3.2 Japan
    5.4.3.3 India
    5.4.3.4 Australia
    5.4.3.5 South Korea
    5.4.3.6 Rest of Asia-Pacific
    5.4.4 Middle East & Africa
    5.4.4.1 GCC
    5.4.4.2 South Africa
    5.4.4.3 Rest of Middle East & Africa
    5.4.5 South America
    5.4.5.1 Brazil
    5.4.5.2 Argentina
    5.4.5.3 Rest of South America

    6 COMPETITIVE LANDSCAPE
    6.1 Company Profiles
    6.1.1 Abbott Laboratories
    6.1.2 Bayer AG
    6.1.3 Eli Lilly and Company
    6.1.4 F. Hoffmann-La Roche
    6.1.5 Hisamitsu Pharmaceutical Co. Inc.
    6.1.6 Merck KGaA
    6.1.7 Mylan NV
    6.1.8 Novartis AG
    6.1.9 Novo Nordisk AS
    6.1.10 Pfizer Inc.

    7 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Electric Bus Market Size and Share 2019 | Global Industry Analysis By Trends, Future Demands, Growth Factors, Emerging Technologies, Prominent Players and Forecast Till 2024

    Global Tissue Diagnostic Market 2019 Industry Size, Segments, Growth Factor, Share and Demand Analysis and 2024 Forecast Research Report

    Global Clinical Analyzer Market 2019 Key Manufacturers, Capacity, Production, Price, Cost, Gross and Revenue Forecast 2024

    Process Flavors Market Size 2019 – Global Share, Leading Company Analysis, Research Methodology, Current and Future Plans by Forecast to 2023

  • Elamal News All Rights Reserved.2019.